NM_000080.4:c.*43T>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000080.4(CHRNE):​c.*43T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00812 in 1,589,882 control chromosomes in the GnomAD database, including 459 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.033 ( 219 hom., cov: 33)
Exomes 𝑓: 0.0055 ( 240 hom. )

Consequence

CHRNE
NM_000080.4 3_prime_UTR

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -3.92

Publications

2 publications found
Variant links:
Genes affected
CHRNE (HGNC:1966): (cholinergic receptor nicotinic epsilon subunit) Acetylcholine receptors at mature mammalian neuromuscular junctions are pentameric protein complexes composed of four subunits in the ratio of two alpha subunits to one beta, one epsilon, and one delta subunit. The acetylcholine receptor changes subunit composition shortly after birth when the epsilon subunit replaces the gamma subunit seen in embryonic receptors. Mutations in the epsilon subunit are associated with congenital myasthenic syndrome. [provided by RefSeq, Sep 2009]
CHRNE Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: Illumina
  • congenital myasthenic syndrome 4A
    Inheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • congenital myasthenic syndrome 4B
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • congenital myasthenic syndrome 4C
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 17-4898693-A-G is Benign according to our data. Variant chr17-4898693-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 254885.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.103 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHRNENM_000080.4 linkc.*43T>C 3_prime_UTR_variant Exon 12 of 12 ENST00000649488.2 NP_000071.1 Q04844
CHRNEXM_017024115.2 linkc.*43T>C 3_prime_UTR_variant Exon 13 of 13 XP_016879604.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHRNEENST00000649488.2 linkc.*43T>C 3_prime_UTR_variant Exon 12 of 12 NM_000080.4 ENSP00000497829.1 Q04844
CHRNEENST00000572438.1 linkn.1211T>C non_coding_transcript_exon_variant Exon 7 of 7 5
CHRNEENST00000652550.1 linkn.1251T>C non_coding_transcript_exon_variant Exon 4 of 4
CHRNEENST00000649830.1 linkc.*161T>C 3_prime_UTR_variant Exon 11 of 11 ENSP00000496907.1 A0A3B3IRM1

Frequencies

GnomAD3 genomes
AF:
0.0327
AC:
4975
AN:
152024
Hom.:
219
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.105
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0187
Gnomad ASJ
AF:
0.0231
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.00254
Gnomad OTH
AF:
0.0325
GnomAD2 exomes
AF:
0.0107
AC:
2273
AN:
212434
AF XY:
0.00878
show subpopulations
Gnomad AFR exome
AF:
0.109
Gnomad AMR exome
AF:
0.0109
Gnomad ASJ exome
AF:
0.0218
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00266
Gnomad OTH exome
AF:
0.0145
GnomAD4 exome
AF:
0.00551
AC:
7928
AN:
1437740
Hom.:
240
Cov.:
33
AF XY:
0.00509
AC XY:
3629
AN XY:
712758
show subpopulations
African (AFR)
AF:
0.112
AC:
3738
AN:
33314
American (AMR)
AF:
0.0121
AC:
484
AN:
39916
Ashkenazi Jewish (ASJ)
AF:
0.0231
AC:
590
AN:
25542
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38962
South Asian (SAS)
AF:
0.000460
AC:
38
AN:
82626
European-Finnish (FIN)
AF:
0.0000789
AC:
4
AN:
50684
Middle Eastern (MID)
AF:
0.0179
AC:
102
AN:
5712
European-Non Finnish (NFE)
AF:
0.00202
AC:
2226
AN:
1101358
Other (OTH)
AF:
0.0125
AC:
746
AN:
59626
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
451
902
1352
1803
2254
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
178
356
534
712
890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0328
AC:
4983
AN:
152142
Hom.:
219
Cov.:
33
AF XY:
0.0316
AC XY:
2350
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.105
AC:
4363
AN:
41502
American (AMR)
AF:
0.0187
AC:
285
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.0231
AC:
80
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.0000943
AC:
1
AN:
10608
Middle Eastern (MID)
AF:
0.0408
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
0.00255
AC:
173
AN:
67970
Other (OTH)
AF:
0.0322
AC:
68
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
234
468
701
935
1169
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0108
Hom.:
13
Bravo
AF:
0.0374
Asia WGS
AF:
0.00808
AC:
28
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Congenital myasthenic syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.14
DANN
Benign
0.24
PhyloP100
-3.9
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2229200; hg19: chr17-4801988; API